Literature DB >> 20164121

High glucose, nitric oxide, and adenosine: a vicious circle in chronic hyperglycaemia?

Assunta Pandolfi, Natalia Di Pietro.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20164121     DOI： 10.1093/cvr/cvq055

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN： 0008-6363            Impact factor:   10.787


× No keyword cloud information.
  10 in total

Review 1.  Is nitric oxide a hormone?

Authors:  Asghar Ghasemi; Saleh Zahediasl
Journal:  Iran Biomed J       Date:  2011

Review 2.  Fetoplacental vascular endothelial dysfunction as an early phenomenon in the programming of human adult diseases in subjects born from gestational diabetes mellitus or obesity in pregnancy.

Authors:  Andrea Leiva; Fabián Pardo; Marco A Ramírez; Marcelo Farías; Paola Casanello; Luis Sobrevia
Journal:  Exp Diabetes Res       Date:  2011-11-24

3.  Fasting cycles potentiate the efficacy of gemcitabine treatment in in vitro and in vivo pancreatic cancer models.

Authors:  Martina D'Aronzo; Manlio Vinciguerra; Tommaso Mazza; Concetta Panebianco; Chiara Saracino; Stephen P Pereira; Paolo Graziano; Valerio Pazienza
Journal:  Oncotarget       Date:  2015-07-30

4.  Effects of berberine on amelioration of hyperglycemia and oxidative stress in high glucose and high fat diet-induced diabetic hamsters in vivo.

Authors:  Cong Liu; Zhuo Wang; Yulong Song; Dan Wu; Xuan Zheng; Ping Li; Jin Jin; Nannan Xu; Ling Li
Journal:  Biomed Res Int       Date:  2015-02-01       Impact factor: 3.411

5.  Anti-inflammatory Effects of Heme Oxygenase-1 Depend on Adenosine A2A- and A2B-Receptor Signaling in Acute Pulmonary Inflammation.

Authors:  Franziska M Konrad; Constantin Zwergel; Kristian-Christos Ngamsri; Jörg Reutershan
Journal:  Front Immunol       Date:  2017-12-20       Impact factor: 7.561

6.  Role of hepatocyte nuclear factor 4 alpha in cell proliferation and gemcitabine resistance in pancreatic adenocarcinoma.

Authors:  Qiqing Sun; Wenyan Xu; Shunrong Ji; Yi Qin; Wensheng Liu; Qiangsheng Hu; Zheng Zhang; Mengqi Liu; Xianjun Yu; Xiaowu Xu
Journal:  Cancer Cell Int       Date:  2019-03-04       Impact factor: 5.722

7.  Insulin-increased L-arginine transport requires A(2A) adenosine receptors activation in human umbilical vein endothelium.

Authors:  Enrique Guzmán-Gutiérrez; Francisco Westermeier; Carlos Salomón; Marcelo González; Fabián Pardo; Andrea Leiva; Luis Sobrevia
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

8.  Multi-targeted mechanisms underlying the endothelial protective effects of the diabetic-safe sweetener erythritol.

Authors:  Daniëlle M P H J Boesten; Alvin Berger; Peter de Cock; Hua Dong; Bruce D Hammock; Gertjan J M den Hartog; Aalt Bast
Journal:  PLoS One       Date:  2013-06-05       Impact factor: 3.240

9.  Modeling interactions between Human Equilibrative Nucleoside Transporter-1 and other factors involved in the response to gemcitabine treatment to predict clinical outcomes in pancreatic ductal adenocarcinoma patients.

Authors:  Francesca Tavano; Andrea Fontana; Fabio Pellegrini; Francesca Paola Burbaci; Francesca Rappa; Francesco Cappello; Massimiliano Copetti; Evaristo Maiello; Lucia Lombardi; Paolo Graziano; Manlio Vinciguerra; Fabio Francesco di Mola; Pierluigi di Sebastiano; Angelo Andriulli; Valerio Pazienza
Journal:  J Transl Med       Date:  2014-09-10       Impact factor: 5.531

10.  Development of a metabolites risk score for one-year mortality risk prediction in pancreatic adenocarcinoma patients.

Authors:  Andrea Fontana; Massimiliano Copetti; Iole Maria Di Gangi; Tommaso Mazza; Francesca Tavano; Domenica Gioffreda; Fulvio Mattivi; Angelo Andriulli; Urska Vrhovsek; Valerio Pazienza
Journal:  Oncotarget       Date:  2016-02-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.